ArticleThe Journal of allergy and clinical immunology2019

Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness.

Milica Grozdanovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.